Laboratorios Farmaceuticos ROVI

ESG Needs Attention 2/6
Country:
Spain
Industry:
Health Care
Climate Performance
ESG data
ESG Targets
  • Laboratorios Farmaceuticos ROVI has a general SDG approach in ESG strategy
  • Climate performance is an area of concern: 0 SDiD points
  • ESG data transparency is good: 2 SDiD points
  • Laboratorios Farmaceuticos ROVI can improve ESG target setting: 0 SDiD points
Laboratorios Farmaceuticos ROVI obtains an ESG needs attention SDiD Score® with 2 out of 6 SDiD points.
Climate Performance
Climate performance trends of the company on selected topics
  • GHG Emissions fluctuated over the past 3 years.
  • Energy use was not measured over the past 3 years.
ESG targets
Implementing ESG commitments involves identification and setting of clear targets that can be readily measured and reported on to stakeholders.
Laboratorios Farmaceuticos ROVI communicates data on 1 ESG targets
Industry benchmark is to report data on 3 ESG targets
Topics on which the company communicates ESG targets.
People programmes
ESG data
Communication of ESG performance data form the basis for communicating the ESG strategy progress, informing company stakeholders, redefining and adjusting approaches to ESG.
Laboratorios Farmaceuticos ROVI communicates data on 6 ESG topics
Industry benchmark is to report data on 4 ESG topics
Topics on which the company communicates ESG data.
Energy
Ren. Energy
Water
GHG Emissions
Waste
Occ. health
SDG
Laboratorios Farmaceuticos ROVI has a general SDG approach in ESG strategy
sdg icon
sdg icon
sdg icon
sdg icon
sdg icon
sdg icon
sdg icon
sdg icon
sdg icon
sdg icon
sdg icon
Absolute data
Company Index Ticker Symbol SDiD Score®GHG emissions (tCO2e)Energy (MWh)Waste (t)Water use (m3/1000 liters)Supplier audits (#)Occupational accident rate
Laboratorios Farmaceuticos ROVI
Health Care
IBEX
ROVI
ESG needs attention
2020 - 5,900
2021 - 6,231
2022 - 7,309
24%
2020 - No data
2021 - No data
2022 - No data
No data
2020 - 5,335
2021 - 6,441
2022 - 8,926
67%
2020 - 150,171
2021 - 182,230
2022 - 206,487
38%
2020 - No data
2021 - No data
2022 - No data
No data
2020 - 4.57
2021 - 7
2022 - 7.03
54%